World Cancer Day
Today is World Cancer Day! ENGAGe is here to help patients with gynaecological cancers.
Today is World Cancer Day! ENGAGe is here to help patients with gynaecological cancers.
ENGAGe Co-Chairs Prof. Jalid Sehouli and Petra Adámková are taking part in the ESGO Council meeting in Berlin, Germany.
This webinar is to help you find the relevant material for the clinical trials project and to discuss with you what you should read and listen to in order to pass the test and obtain a certificate. The speaker: Ms. Birthe Lemley Audience: New participants of the CT project
This project is lead by ENAGe, ESGO and AstraZeneca. The aim of this project is to optimize the experience and survival of women with ovarian cancer by 2025. Of you want to take part in, please, register here. Please note, that the webinar is open to ENGAGe members only!
Members of the ENGAGe Executive Group (EEG) will meet on its regular online meeting.
The Ovarian Cancer Commitment (OCC) represents a coalition between ENGAGe, ESGO and AstraZeneca, and aims to improve the experience and survival of people living with ovarian cancer. The OCC is focused on creating a movement in ovarian cancer care, highlighting the importance of improving access to rapid diagnosis, biomarker testing and specialised care, with the aim of improving the quality of life of…
ENGAGe will organise together with ESGO Prevention Committee a webinar on Cervical Cancer Myth. Registration open for ENGAGe members only here.
The members of ENGAGe Executive Group will meet in Berlin.
In the framework of World Ovarian Cancer Day (WOCD), ENGAGe is organising a webinar about Ovarian Cancer. Main speaker will be Prof. Jalid Sehouli.
Members of the ENGAGe Executive Group (EEG) will meet on its regular online meeting.
ENGAGe is proud partner within Risk-based Screening for Cervical Cancer (RISCC) project. More information can be found here.
The presenters are: Dr. Florentia Fostira, PhD, Greece, on Ovarian Cancer: Hereditary Aspects, BRCA1/2 and beyond Prof. Carien Creutzberg, The Netherlands, on Endometrial cancer: update on the molecular classification and genetic aspects For participants of the Clinical trials project only!